SINTX jumps as US FDA clears reconstructive foot surgery implant

SINTX Technologies

20/10/2025 12:44

** Shares of medical device maker SINTX Technologies SINT.O surge 12.3% to $4.45 premarket

** Co says U.S. FDA cleared its Sinaptic implant system for reconstructive foot and ankle surgery

** Device uses silicon nitride, a ceramic that helps bone growth and resists bacteria - SINT

** Co says U.S. launch planned in Q1 2026

** Industry estimates place the global foot & ankle device market at approximately $4.75–$5.4 billion in 2024 - SINT

** Implant designed for single-use with better imaging visibility than metal alternatives - SINT

** Co says system could improve surgical precision and reduce infection risk

** Up to last close, stock up ~13 YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.pandey@thomsonreuters.com))